EHS
EHS

E484K mutation may confer immune evasion capability on UK variant of SARS-CoV-2




A new medRxiv* preprint reports the immunomodulatory effect of the E484K mutation newly acquired by the United Kingdom (U.K.) variant.

Source link

EHS
Back to top button